Kumaravel, J. J., Anbalagan, G., Elangovan, D., Selvamani, M., & Subramanian, B. Tumor microenvironment immunotherapy: Transforming cancer treatment and immune checkpoint inhibitors - Future directions and challenges. Elsevier.
Chicago Style (17th ed.) CitationKumaravel, Jeeva Jothi, Geetha Anbalagan, Dilipan Elangovan, Muthamizh Selvamani, and Balachandran Subramanian. Tumor Microenvironment Immunotherapy: Transforming Cancer Treatment and Immune Checkpoint Inhibitors - Future Directions and Challenges. Elsevier.
MLA (9th ed.) CitationKumaravel, Jeeva Jothi, et al. Tumor Microenvironment Immunotherapy: Transforming Cancer Treatment and Immune Checkpoint Inhibitors - Future Directions and Challenges. Elsevier.
Warning: These citations may not always be 100% accurate.